SCHEMBL271773

SCHEMBL271773

[CH2]C(C)(O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2806747 1.00
SCHEMBL3033018 0.78
SCHEMBL93438 0.78
SCHEMBL178124 0.77
SCHEMBL1436764 0.75
SCHEMBL270674 0.75
SCHEMBL28299907 0.75 TSHR (0.33)
SCHEMBL2801833 0.74
SCHEMBL635712 0.73
SCHEMBL12478173 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017108744-A1 NOVEL SUBSTITUTED INDAZOLES, METHODS FOR PRODUCING SAME, PHARMACEUTICAL PREPARATIONS THAT CONTAIN SAME, AND USE OF SAME TO PRODUCE DRUGS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-06-29 WO claimed
CN-101223158-B N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives BANYU PHARMA CO LTD 2013-01-09 CN claimed
EP-1914232-B1 N-DIHYDROXYALKYL-SUBSTITUTED 2-OXOIMIDAZOLE DERIVATIVES BANYU PHARMA CO LTD (JP) 2010-12-15 EP claimed
CN-101223158-A N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives BANYU PHARMA CO LTD (JP) 2008-07-16 CN claimed
US-20080103178-A1 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives MSD K.K. (JP) 2008-05-01 US claimed
EP-1914232-A1 N-DIHYDROXYALKYL-SUBSTITUTED 2-OXOIMIDAZOLE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-04-23 EP claimed
US-7300947-B2 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-11-27 US claimed
US-20070015792-A1 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives MSD K.K. (JP) 2007-01-18 US claimed
WO-2005019186-A1 2-AMINOBENZIMIDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF HIV/AIDS BAYER HEALTHCARE AG (DE) 2005-03-03 WO claimed
CN-113423470-B Cosmetic compounding agent, cosmetic, and method for producing same 三吉油脂株式会社 2024-07-09 CN disclosed
WO-2024095926-A1 CLEANING LIQUID AND SUBSTRATE CLEANING METHOD 東京応化工業株式会社 2024-05-10 WO disclosed
US-20240057587-A1 ORGANIC AMMONIUM SALT AND HYDROGEN-BONDING MATERIAL TREATMENT AGENT USING SAME MIYOSHI OIL & FAT CO.,LTD. (JP) 2024-02-22 US disclosed
EP-3766969-B1 BIOCATALYST SOLVENT USING IONIC LIQUID, AND BIOCATALYST SOLUTION CONTAINING BIOCATALYST AND SAID SOLVENT MIYOSHI YUSHI KK (JP) 2023-10-04 EP disclosed
US-20230174892-A1 DETERGENT COMPOSITION AND CHEMICAL-MECHANICAL POLISHING COMPOSITION DAICEL CORPORATION (JP) 2023-06-08 US disclosed
EP-0530442-A1 Process for producing a hydroxy-substituted poly (phenylene ether) resin MITSUBISHI CHEMICAL CORPORATION (JP) 1993-03-10 EP disclosed
EP-0184800-B1 OXYGEN PERMEABLE SOFT CONTACT LENS MATERIAL Toyo Contact Lens Co., Ltd. (JP) 1992-04-29 EP disclosed
US-4847012-A Vitamin D related compounds and processes for their preparation WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1989-07-11 US disclosed
US-4649184-A UNSATURATED POLYSILOXANE COPOLYMER WITH MONOMER HAVING SIYLATED HYDROXYL GROUPS TOYO CONTACT LENS CO., LTD. (JP) 1987-03-10 US disclosed
EP-0184800-A2 Oxygen permeable soft contact lens material Toyo Contact Lens Co., Ltd. (JP) 1986-06-18 EP disclosed
US-4012390-A ANTITUMOR AGENTS ELI LILLY AND COMPANY (US) 1977-03-15 US disclosed